Quality Control News and Research

RSS

HORIBA Medical’s new HELO fully automated hematology platform installed at Torbay Hospital

HORIBA UK Ltd, Medical announces the first global installation of its new HELO high throughput fully automated hematology platform in Torbay Hospital.

From HORIBA Medical 4 Oct 2018

Beckman Coulter introduces Kaluza C software to improve clinical reporting

Beckman Coulter has launched the Kaluza C Flow Cytometry Analysis Software, an advanced data analysis system for the clinical laboratory.

From Beckman Coulter Life Sciences - Flow Cytometry 3 Oct 2018

New diagnostic tool utilizes ultrasound to measure intracranial pressure post accidents

A new study confirms the efficacy of a new diagnostic tool that utilizes ultrasound to measure intracranial pressure following accidents. The technology will now be provided with artificial intelligence so that ambulance personnel can carry out examinations at accident scenes.

3 Oct 2018

Research reveals how critical oocyte quality control process works

Females are born with a finite number of eggs that are steadily depleted throughout their lifetime. This reserve of eggs is selected from a much larger pool of millions of precursor cells, or oocytes, that form during fetal life.

28 Sep 2018

Foundation for a Smoke-Free World calls for proposals to implement Smoke-Free Index

The Foundation for a Smoke-Free World today announced at the Global Tobacco and Nicotine Forum that it is calling for proposals to develop and implement the Smoke-Free Index.

24 Sep 2018

IME Medical Electrospinning establishes state-of-the-art manufacturing lab facilities

Medical Technology company IME Medical Electrospinning, developer, producer and scientific partner in the field of biomedical electrospinning processes and equipment, today announced that its high-end laboratory and a brand new set of cleanrooms have become operational.

24 Sep 2018

Innovation Fund Denmark supports research project that aims to fight Clostridium difficile diarrhea

One man's trash is another man's treasure, as the saying goes. If things go to plan, feces from registered and thoroughly tested healthy donors will in a few years be the standard treatment for the bacterium Clostridium difficile at Danish hospitals.

21 Sep 2018

Novel mathematical approach uncovers existence of unsuspected biological cycles

A novel mathematical approach has uncovered that some animal cells have robust 12-hour cycles of genetic activity, in addition to circadian or 24-hour cycles.

20 Sep 2018

Logos Biosystems releases new electrophoretic tissue clearing system with twice the features in half the space

Logos Biosystems has released the latest system for electrophoretic tissue clearing, the X-CLARITY™ Tissue Clearing System II. The new system has been upgraded with new features that make it streamlined, easier to use and more intuitive.

From Logos Biosystems 18 Sep 2018

Salk research in yeast leads to serendipitous finding about hypomyelinating leukodystrophy

Studying the fundamental aspects of biology can sometimes lead to unexpected findings that directly relate to human disease. In one of the latest examples of scientific serendipity, researchers from the Salk Institute found that an important quality control mechanism in baker's yeast is closely connected to hypomyelinating leukodystrophy, a debilitating disease found in children.

17 Sep 2018

ASU joins with Mayo Clinic to move blue clays closer to medical use

Researchers at Arizona State University and the Mayo Clinic in Rochester, Minnesota, have found that at least one type of blue clay may help fight disease-causing bacteria in wounds, including antibiotic-resistant bacteria. The findings appear in the International Journal of Antimicrobial Agents.

21 Aug 2018

Clay may help fight disease-causing bacteria in wounds

The use of mud or wet clay as a topical skin treatment or a poultice is a common practice in some cultures and the concept of using mud as medicine goes back to earliest times.

21 Aug 2018

RDMD raises $3 million in seed funding to accelerate rare disease research, drug development

RDMD, a healthcare technology company dedicated to accelerating research for patients with rare diseases, today announced that it has raised $3 million in seed financing.

20 Aug 2018

URI professor develops simpler and quicker method for detecting impurity in heparin

In 2008, a contaminant eluded the quality safeguards in the pharmaceutical industry and infiltrated a large portion of the supply of the popular blood thinner heparin, sickening hundreds and killing about 100 in the U.S.

19 Aug 2018

Researchers describe link between poor oocyte development and oxidative stress in obese mice

Excessive body fat is associated with negative effects on female fertility and pregnancy. In mice, maternal obesity impairs proper development of egg precursor cells called oocytes.

17 Aug 2018

Study finds prevalence of substandard and falsified medicines in developing countries

A new study from the University of North Carolina at Chapel Hill found that substandard and falsified medicines, including medicines to treat malaria, are a serious problem in much of the world.

10 Aug 2018

Researchers engineer three cell lines to produce nonproprietary versions of NISTmAb

When the National Institute of Standards and Technology issued the world's first standardized monoclonal antibody in July 2016, the exhaustively analyzed protein known as NISTmAb was intended as a valuable tool for biopharmaceutical companies.

1 Aug 2018

Beckman Coulter launches DURA Innovations global flow cytometry business tools

Beckman Coulter Life Sciences expands services by placing DURA Innovations dry reagent solutions at the heart of enhanced external business resources for lab.

From Beckman Coulter Life Sciences - Flow Cytometry 30 Jul 2018

Study: Reducing systolic blood pressure lowers MCI, dementia risk

Lowering one's blood pressure is beneficial not only for the heart, but also for the mind. For the first time, researchers have proved that lowering systolic blood pressure to 120 mm Hg or less reduces the risk of mild cognitive impairment, which in turn, reduces one's risk of developing Alzheimer's disease or dementia.

27 Jul 2018

Scientists use new drug discovery system to target Huntington’s Disease

Scientists have used a new drug discovery system to specifically target phosphatases in Huntington's, which were previously thought to be undruggable.